Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Fund News: David Tepper, Kyle Bass & Viking Global

Page 1 of 2

Billionaire hedge fund manager David Tepper is short the euro (LeapRate)
David Tepper, the founder of hedge fund Appaloosa Management, said that he’s short the euro during a talk at the Robin Hood Investors Conference in New York City. Tepper, whose fund specializes in distressed debt, said he expects that the European Central Bank will need to expand its balance sheet by instituting more quantitative easing and further “loosening” monetary policy to stimulate the eurozone’s flagging economy. Early on Tuesday, news reports surfaced that the ECB is weighing whether it should start buying corporate bonds, sending the euro back to the downside after a brief respite. The pair last traded on Wednesday below the $1.2700 handle.


Cincinnati investors targeted for New York hedge fund (BizJournals)
A Cincinnati native who is the son of one of the local business community’s best-known CEOs has launched a hedge fund in New York. Daniel Barach, the son of former U.S. Shoe CEO Phil Barach, is targeting Cincinnati investors to put money into the fund, known as Turnaround Stocks L.P. “I’m born and raised in Cincinnati, and I believe I can help people make a lot of money,” Barach told me. “I have a lot of loyalty to my hometown. There’s a connection.” Barach has quite a track record. He ran a similar hedge fund – MLT Capital – for 11 years, building it into a $150 million operation before shutting it down when the stock market collapsed in 2008. Then, he temporarily retired.

Kyle Bass warns QE end will shake up markets (CNBC)
Central banks meeting next week will expose a huge divergence in monetary policy between several major economies, putting the macro environment in focus and weighing on foreign exchange, hedge fund manager Kyle Bass said Wednesday. The founder of the $1.7 billion hedge fund Hayman Capital thinks the Fed likely will taper its bond-buying stimulus to zero next week. The Bank of Japan, however, likely will announce it will do whatever it takes to prevent the world’s third-largest economy from heading into a major crisis.

Lone Pine Posts Gains But Remains Down for the Year (InstitutionalInvestorsAlpha)
Most of the hedge funds managed by Stephen Mandel Jr.’s Lone Pine Capital posted modest gains in the third quarter. However, they still remained mired in the red for the year. According to the Greenwich, Connecticut-based firm’s latest report to clients dated October 14, third quarter returns ranged from flat for the long-only fund, Lone Cascade, to up 2.7 percent for Lone Tamarack, its new long-short fund. Lone Pine told clients that both longs and shorts outperformed global market indexes in the most recent three-month period.

Herbalife Bull Is Back, More Bullish Than Ever (WSJ)
One of Herbalife Ltd. (NYSE:HLF) -6.19% most bullish analysts is back. He’s with a new firm, but he has the same optimistic views on the controversial maker of nutritional supplements. …Mr. Ackman has alleged the company should be shuttered and its stock price should go to zero. Herbalife has said it complies with all laws and regulations and welcomed the inquiry as a chance to clear its name. For his part, Mr. Ramey now predicts the investigation will ultimately lead to a settlement between Herbalife and the FTC in which the company gets a fine or sanctions, but won’t get shut down.

Sector winners since the dip (CNBC)

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!